Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 27, 2017
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI
Bill Sutherland Initiated (AMED) at Hold and Held Target at $50 on, Jan 27th, 2017
Bill Sutherland of Benchmark, Initiated "Amedisys, Inc." (AMED) at Hold and Held Target at $50 on, Jan 27th, 2017.
Bill has made no other calls on AMED in the last 4 months.
There are 2 other peers that have a rating on AMED. Out of the 2 peers that are also analyzing AMED, 1 agrees with Bill's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Sheryl Skolnick of "Mizuho" Downgraded from Strong Buy to Hold on, Wednesday, November 9th, 2016
This is the rating of the analyst that currently disagrees with Bill
- Kevin Ellich of "Craig-Hallum" Initiated at Strong Buy and Held Target at $48 on, Friday, December 16th, 2016
